Table 1.
Distribution of rabies-related scientific articles from Mainland China by category group, 1963 – 2012
| |
Scientific articles |
|||
|---|---|---|---|---|
| In English, n = 114 | In Chinese, n = 75 | Total, N = 189 | % | |
|
Journal type |
|
|
|
|
| General |
101 |
16 |
117 |
61.9% |
| Human |
11 |
59 |
70 |
37.0% |
| Animal |
2 |
0 |
2 |
1.1% |
|
Sector |
|
|
|
|
| Human |
56 |
61 |
117 |
61.9% |
| Animal |
36 |
4 |
40 |
21.2% |
| General |
22 |
10 |
32 |
16.9% |
|
Setting |
|
|
|
|
| Lab-based |
86 |
49 |
135 |
71.4% |
| Clinical/facility-based |
15 |
8 |
23 |
12.2% |
| Urban community based |
1 |
3 |
4 |
2.1% |
| Urban-Rural (mixed) |
11 |
14 |
25 |
13.2% |
| Occupational |
0 |
0 |
0 |
0.0% |
| Rural community based |
1 |
1 |
2 |
1.1% |
|
Species |
|
|
|
|
| Pathogen |
59 |
37 |
96 |
50.8% |
| Human |
30 |
29 |
59 |
31.2% |
| Dog |
11 |
3 |
14 |
7.4% |
| Multiple animals |
14 |
6 |
20 |
10.6% |
|
Immuno-genetics |
19 |
11 |
30 |
|
|
Basic epidemiology |
36 |
27 |
63 |
100.0% |
| Case studies or outbreak reports in humans and animals |
17 |
4 |
21 |
33.3% |
| Seroprevalence in animals |
3 |
4 |
7 |
11.1% |
| Surveillance data and risk factors |
6 |
14 |
20 |
31.7% |
| *PEP patients’ analysis |
9 |
1 |
10 |
15.9% |
| Costs of treatment |
0 |
1 |
1 |
1.6% |
| Level of awareness in public and health care workers |
1 |
3 |
4 |
6.3% |
|
Vaccines and diagnostics development |
26 |
10 |
36 |
|
|
Virology - Molecular epidemiology |
30 |
20 |
50 |
100.0% |
| Virology |
11 |
15 |
26 |
52.0% |
| Molecular epidemiology |
14 |
3 |
17 |
34.0% |
| Modeling - dynamics |
5 |
2 |
7 |
14.0% |
|
Review |
4 |
6 |
10 |
|
|
Evidence based policies and systems analysis |
0 |
0 |
0 |
|
|
Evidence-based practices or new interventions |
|
|
|
|
| Dogs management |
0 |
0 |
0 |
|
| Caracteristics of dogs: pop. estimates/of owned |
0 |
0 |
0 |
|
| Development of Monitoring and Evaluation tools |
0 |
0 |
0 |
|
|
Evidence-based advocacy |
|
|
|
|
| Disease burden - incidence |
0 |
0 |
0 |
|
| Cost of illness | 0 | 0 | 0 | |
*PEP: Post-exposure prophylaxis.